Latest

GSK and PATH welcome results from small early-stage trial that suggests changing the dosing schedule of the candidate malaria vaccine RTS,S may improve its efficacy
Press release
6 Sep 2016
Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay
Publication
29 Jul 2016
Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO Stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial
Publication
6 Jul 2016
Optimization of a membrane feeding assay for Plasmodium vivax infection in Anopheles albimanus
Publication
29 Jun 2016
GSK and PATH welcome commitment by Gavi, the Vaccine Alliance, to co-fund pilot implementation programme for RTS,S malaria vaccine candidate in Africa
Press release
23 Jun 2016
The challenges of malaria vaccine “challenge” trials: mosquitoes travel in business class to infect American volunteers—but fare better in economy
Feature
22 Jun 2016
Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S/AS01B with chimpanzee adenovirus 63 and modified vaccinia Ankara vectored vaccines expressing ME-TRAP
Publication
15 Jun 2016
The 2016 Vaccine Development Pipeline
Publication
14 Jun 2016
Status of vaccine research and development of vaccines for malaria
Publication
14 Jun 2016
Fractional third and fourth dose of RTS,S/AS01 malaria candidate vaccine: a phase 2a controlled human malaria infection and immunogenicity study
Publication
13 Jun 2016
The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity
Publication
31 May 2016
Science of Eradication: Malaria Core Course
Event
12 Jun 2016